View Older Stories View More Recent Stories
-
Genocea Initiates Restructuring and Announces Plan to Explore Strategic Alternatives
-
Fortune Brands Announces Intent to Separate Into Two World Class Publicly Traded Companies; Reports 1Q 2022 Results Ahead of Consensus and Raises Full-Year EPS Outlook While Maintaining Operational Gu
-
Genocea Initiates Restructuring and Announces Plan to Explore Strategic Alternatives
-
Robinhood Reports First Quarter 2022 Results
-
Robinhood Reports First Quarter 2022 Results
-
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2022
-
Travel + Leisure Co. Reports First Quarter 2022 Results and Provides Full Year 2022 Guidance
-
Spanish quarterly unemployment ticks up for first time since Q3 2020
-
Analysis-China struggles for options as COVID threatens economic goals
-
Robinhood Markets (HOOD) Creates an Inflection to Profitability via Massive Layoff - Morgan Stanley
-
Solid Biosciences (SLDB) Announces Updated Corporate Strategy to Develop SGT-001 and SGT-003 Pipeline Programs for Patients with Duchenne Muscular Dystrophy
-
Solid Biosciences Announces Updated Corporate Strategy to Develop SGT-001 and SGT-003 Pipeline Programs for Patients with Duchenne Muscular Dystrophy
-
Temasek-backed oil rig builders agree $6.3 billion merger amid sector downturn
-
Identity check contractor ID.me fires dozens on fraud team as Congress probes
-
Identity check contractor ID.me fires dozens on fraud team as Congress probes
-
CN Reports First Quarter Results
-
Provar Joins With Supermums to Address Talent Shortage in Salesforce Automation
-
Bioventus (BVS) Reports Prelim Q1 Sales of $116.5M-$118.5M, Adjusted EBITDA of ($19.4M)-($19M)
-
Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA
-
Nektar Therapeutics (NKTR) is implementing a cost restructuring plan
-
Nektar Therapeutics Announces Strategic Reorganization Plan and Corporate Outlook
-
Rising energy prices push almost half German companies to cut new investments - survey
-
Big business joins forces to bridge Germany's growing skills gap
-
Mary Kay Inc. Announces Winners of NFTE World Series of Innovation Challenge
-
JLL Income Property Trust Acquires Luxury Apartment Community in Suburban Orlando
-
Crosschq Announces New Solution Designed to Help Companies and Laid-off Workers During Workforce Optimization Challenges
-
Xerox Releases First-Quarter Results
-
Dow (DOW) Plans to Expand alkoxylation Capacity in the US and Europe
-
Dow announces new alkoxylation capacity in U.S. and Europe to meet continued robust demand growth
-
Dow reports first quarter 2022 results
-
Finch Therapeutics (FNCH) Announces Workforce Restructuring to Focus Resources on Key Development Programs
-
Finch Therapeutics Announces Workforce Restructuring to Focus Resources on Key Development Programs
-
Finch Therapeutics Announces Workforce Restructuring to Focus Resources on Key Development Programs
-
Cairo's Ramadan street feasts return after coronavirus suspension
-
Dow announces results from 2022 Annual Stockholder Meeting
-
Dow announces new $3 billion share repurchase program; declares quarterly dividend of 70 cents per share
-
Analysis-Russian workers face new reality as Ukraine war sanctions sap job prospects
-
Latin women bear the heaviest burden of caregiving labor: Angélica Fuentes Téllez
-
ProQR Announces Additional Sepofarsen Illuminate Trial Analyses and Provides Update on Company Strategy
-
ProQR Announces Additional Sepofarsen Illuminate Trial Analyses and Provides Update on Company Strategy
-
Analysis-Canada's accelerated timetable for EVs brings spotlight on key bill
-
Russian lawmakers propose giving VEB control in firms that leave Russia
-
China gaming firms toe the line, paving the way to end licence freeze
-
Growth to continue in 2022, but pandemic and geopolitical uncertainties bring considerable risk to Canadian economy
-
Biz2Credit Small Business Lending Index™ for March 2022 Finds Approval Rates Rise Again at Banks and Some Non-Bank Lenders
-
Growth in Germany to fall to 1.5%, labour minister warns - Bild am Sonntag
-
Akebia Therapeutics (AKBA) Announces 42% Workforce Reduction to Conserve Cash
-
H.C. Wainwright Reiterates Neutral Rating, $2 PT on Akebia Therapeutics (AKBA)
-
Leveraging Intel Technology as a Force for Good
-
Labor Forecast Predicts 7.4% Increase in Demand for Temporary Workers for 2022 Second Quarter, Signaling Further Signs of Recovery Ahead

